Product · #16 of 27 · multi-symptom

Happy V Menopause Relief AM + PM

Capsule (am + pm) from Happy V, made by Happy V. Daily serving: 1 AM capsule + 1 PM capsule.

Last updated · Price and ratings checked Nov 19, 2026

In short: Happy V Menopause Relief AM + PM scores 48.9/100 in our ranking (#16 of 27). It costs $2.00 a day at the regular price. Evidence: pollen extract + genistein 40 mg; no product trial; best ingredient grade B- (Soy isoflavones & genistein). No NSF registry listing was confirmed.

Pros

  • None stood out.

Cons

  • No NSF registry listing confirmed.
  • Expensive: $2.00 a day at the label dose.

Flags

Drug interactionsEstrogen metabolism

Score breakdown

Evidence
22/40
NSF-verified testing
4/20
Value ($/day)
8.9/20
Ingredients
10/10
Amazon rating
4/10

How we score

Full label: what's in it

Supplement Facts actives per daily serving (1 AM capsule + 1 PM capsule). Source: label or official page, checked Nov 19, 2026.
Ingredient (as labeled)Per dayEvidence page
Graminex G63 flower pollen extract (AM 160 + PM 160)320 mgFlower pollen extract C
DIM (AM)100 mgDIM D
Lifenol hop extract (AM)85 mgHops (8-PN) C-
Sensoril ashwagandha (AM 75 + PM 75)150 mgAshwagandha C
Genistein from Sophora japonica (AM)40 mgSoy isoflavones & genistein B-
BroccoRaphanin Plus broccoli seed extract (AM)25 mgNot in our evidence library
HMRlignan Norway spruce lignans (AM 18 + PM 18)36 mgNot in our evidence library
Red clover extract (PM)75 mgRed clover C+
5-HTP (PM)75 mgNot in our evidence library
Vitamin B6 (AM 1.7 pyridoxine + PM 20 P5P)21.7 mgNot in our evidence library
Vitamin B12 (AM)2.4 mcgNot in our evidence library
Magnesium (PM)25 mgMagnesium D
Zinc (PM)18 mgNot in our evidence library

Full Supplement Facts are on the official page.

Evidence

Our evidence score: 22/40, because: pollen extract + genistein 40 mg; no product trial.

Product-level research: we found no published trial of this exact product, so its evidence comes from studies of its ingredients.

Ingredient evidence

  • Flower pollen extract C (320 mg here)
    Purified flower-pollen extract (the active in Relizen) is a non-hormonal ingredient studied for occasional hot flashes and night sweats*. Only two small placebo-controlled trials exist, and pooled controlled data were not statistically significant. The Menopause Society 2023: Not recommended (Level III).
  • DIM D (100 mg here)
    DIM (3,3'-diindolylmethane) changes how the body breaks down estrogen. Its effect on menopause symptoms has not been tested in a single clinical trial. The Menopause Society 2023: Not assessed.
  • Hops (8-PN) C- (85 mg here)
    Hop extract, a source of the potent plant estrogen 8-prenylnaringenin (8-PN), has been studied in a few small trials for occasional hot flashes*, with mixed results. The Menopause Society 2023: Not assessed.
  • Ashwagandha C (150 mg here)
    Ashwagandha root extract has been studied for occasional stress, sleep quality and common symptoms in perimenopause and menopause* in a few small placebo-controlled trials, all run in India. The Menopause Society 2023: Not assessed.
  • Soy isoflavones & genistein B- (40 mg here)
    Soy isoflavones (including genistein) are the most widely studied supplement group for occasional hot flashes associated with menopause*. Meta-analyses find modest average effects, such as about 20% fewer hot flashes than placebo in one analysis, and results vary between trials. The Menopause Society 2023: Not recommended (Level II) – mixed evidence.
  • Red clover C+ (75 mg here)
    Red clover isoflavones have been studied for occasional hot flashes*. Some meta-analyses report short-term effects, but a 12-month NIH-funded trial and a Cochrane review found no clear benefit over placebo. The Menopause Society 2023: Not specifically named (supplements not recommended).
  • Magnesium D (25 mg here)
    Magnesium supports normal muscle and nerve function*. In the one large menopause trial (289 women), it did not reduce hot flashes compared with placebo. The Menopause Society 2023: Not assessed.

Studies

Studies on its ingredients (20)
  • Femal, a herbal remedy made from pollen extracts, reduces hot flushes and improves quality of life in menopausal women: a randomized, placebo-controlled, parallel study.

    Winther K, Rein E, Hedman C · Climacteric 2005 · Flower pollen extract

    64 women took Femal flower-pollen extract or placebo for 3 months; 54 finished. Hot flashes fell more on the pollen extract, but this is a single small study.

    Who
    64 randomized (54 completed)
    Dose
    Femal (pollen extract) 2 tablets/day
    Duration
    3 months
    Result
    65% responders vs 38% placebo (P<.006); diary hot flushes 27% lower vs placebo.
    Funding
    Not stated in abstract (Femal is a Natumin Pharma product). Funding not stated

    PubMed · Full text (DOI)

  • The efficacy of purified pollen extract for reducing vasomotor symptoms in women: a systematic review and meta-analysis.

    Acquarulo EL, Hernandez EC, Kodzodziku F et al. · Menopause 2024 · Flower pollen extract

    Researchers pooled every study of the pollen extract in Relizen. Women improved over 3 months, but when compared with placebo the difference disappeared, suggesting much of the benefit may be placebo. No significant side effects were seen.

    Who
    5 studies (1 RCT + 4 observational), 420 women
    Dose
    purified cytoplasm of pollen (PureCyTonin/Relizen)
    Duration
    3 months
    Result
    Large improvements before-vs-after, but when only controlled studies were pooled the effect was not statistically significant – may be placebo effect.
    Funding
    Authors reported no conflicts. Independent / academic

    PubMed · Full text (DOI)

  • A prospective, multicenter, randomized, double-blind placebo-controlled trial on purified and specific Cytoplasmic pollen extract for hot flashes in breast cancer survivors.

    Bounous VE, Cipullo I, D'Alonzo M et al. · Gynecol Endocrinol 2024 · Flower pollen extract

    39 breast-cancer survivors took the Relizen pollen ingredient or placebo for 3 months. Hot flashes fell in the active group, but the trial was very small and mainly compared women to their own starting point.

    Who
    39 breast-cancer survivors
    Dose
    PureCyTonin (Relizen/Sérélys ingredient)
    Duration
    3 months
    Result
    Fewer diary hot flashes vs baseline (P=.02) in the active group; well tolerated.
    Funding
    Not stated in abstract. Funding not stated

    PubMed · Full text (DOI)

  • The impact of 3,3'-diindolylmethane on estradiol and estrogen metabolism in postmenopausal women using a transdermal estradiol patch.

    Newman MS, Smeaton J · Menopause 2025 · DIM

    In women already using an estrogen patch, those also taking DIM had clearly different estrogen breakdown products in urine, raising the possibility that DIM could interfere with hormone therapy. There are no trials showing DIM relieves menopause symptoms.

    Who
    postmenopausal women on transdermal estradiol (observational)
    Dose
    DIM supplement
    Duration
    cross-sectional
    Result
    DIM significantly altered 6 of 10 urinary estrogen metabolites; may blunt hormone therapy.
    Funding
    Not stated in abstract. Funding not stated

    PubMed · Full text (DOI)

  • A first prospective, randomized, double-blind, placebo-controlled study on the use of a standardized hop extract to alleviate menopausal discomforts.

    Heyerick A, Vervarcke S, Depypere H et al. · Maturitas 2006 · Hops (8-PN)

    67 Belgian women took a hop extract or placebo for 12 weeks. There was an early benefit at 6 weeks that was no longer significant at 12 weeks.

    Who
    67 women
    Dose
    hop extract 100 or 250 µg 8-PN/day
    Duration
    12 weeks
    Result
    100 µg beat placebo at 6 weeks but not 12 weeks; no dose-response.
    Funding
    Not stated in abstract. Funding not stated

    PubMed · Full text (DOI)

  • A randomized, double-blind, placebo-controlled, cross-over pilot study on the use of a standardized hop extract to alleviate menopausal discomforts.

    Erkkola R, Vervarcke S, Vansteelandt S et al. · Phytomedicine 2010 · Hops (8-PN)

    36 Finnish women took a hop extract and placebo for 8 weeks each. Overall it did not beat placebo.

    Who
    36 women (crossover)
    Dose
    standardized hop extract
    Duration
    16 weeks (8+8)
    Result
    No significant overall effect; some time-specific improvements.
    Funding
    Not stated in abstract. Funding not stated

    PubMed · Full text (DOI)

  • The effect of Hop (Humulus lupulus L.) on early menopausal symptoms and hot flashes: A randomized placebo-controlled trial.

    Aghamiri V, Mirghafourvand M, Mohammad-Alizadeh-Charandabi S et al. · Complement Ther Clin Pract 2016 · Hops (8-PN)

    120 Iranian women took hops or placebo for 12 weeks and reported fewer hot flashes with hops. One unreplicated study.

    Who
    120 women (Iran)
    Dose
    hop tablets
    Duration
    12 weeks
    Result
    Greene score and hot-flash counts lower vs placebo at weeks 4, 8, 12.
    Funding
    Academic (Tabriz Univ.). Independent / academic

    PubMed · Full text (DOI)

  • Effect of an ashwagandha (Withania Somnifera) root extract on climacteric symptoms in women during perimenopause: A randomized, double-blind, placebo-controlled study.

    Gopal S, Ajgaonkar A, Kanchi P et al. · J Obstet Gynaecol Res 2021 · Ashwagandha

    100 Indian women in perimenopause took ashwagandha root extract (300 mg twice a day) or placebo for 8 weeks. Menopause symptoms and quality of life improved more with ashwagandha, and hormone levels shifted. The study was short and not yet repeated outside India.

    Who
    100 perimenopausal women (91 completed)
    Dose
    ashwagandha root extract 300 mg twice daily
    Duration
    8 weeks
    Result
    Total MRS and MENQoL improved vs placebo; estradiol up, FSH/LH down.
    Funding
    Not stated in abstract; Indian investigators (ingredient-supplier funding typical but not verified). Funding not stated

    PubMed · Full text (DOI)

  • A prospective, randomized, double-blind, placebo-controlled study on efficacy and safety of Ashwagandha root extract (Withania somnifera) for managing menopausal symptoms in women.

    Vani I, Muralidhar G, Rao BS · Front Reprod Health 2025 · Ashwagandha

    60 Indian women took ashwagandha root extract or placebo for 8 weeks; symptoms, hot flashes and stress improved more with ashwagandha. Small and short.

    Who
    60 women aged 45–55
    Dose
    ashwagandha root extract
    Duration
    56 days
    Result
    MRS, hot-flash events and stress scores improved vs placebo.
    Funding
    Authors declared no conflicts. Independent / academic

    PubMed · Full text (DOI)

  • Effects of Withania somnifera root extract on sleep quality, body composition, and menopausal symptoms in postmenopausal women: a randomized, double-blind, placebo-controlled trial.

    Obhrai S, Shenoy S, Arora M · Menopause 2026 · Ashwagandha

    66 Indian postmenopausal women took ashwagandha 600 mg a day or placebo for 12 weeks; sleep and menopause symptoms improved more with ashwagandha.

    Who
    66 postmenopausal women (63 completed)
    Dose
    ashwagandha root extract 600 mg/day
    Duration
    12 weeks
    Result
    Better sleep quality (PSQI -5.2 vs -0.8), menopause symptoms and body fat vs placebo; no BMD change.
    Funding
    No conflicts reported. Independent / academic

    PubMed · Full text (DOI)

  • Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial.

    Newton KM, Reed SD, LaCroix AZ et al. · Ann Intern Med 2006 · Black cohosh, Soy isoflavones & genistein

    The US government-funded HALT study followed 351 women for a year. Black cohosh (160 mg a day), a 10-herb blend, and the blend plus more soy food did no better than a dummy pill for hot flashes, while hormone therapy clearly worked.

    Who
    351 women aged 45–55
    Dose
    black cohosh 160 mg/day; multibotanical; multibotanical + soy diet; hormone therapy; placebo
    Duration
    12 months
    Result
    No herbal arm differed from placebo at 3, 6 or 12 months (<1 hot flash/day difference); hormone therapy reduced ~4 symptoms/day vs placebo.
    Funding
    US NIH (NCCAM/NIA) – HALT study, independent. Independent / academic

    PubMed · Full text (DOI)

  • Phytoestrogens for menopausal vasomotor symptoms.

    Lethaby A, Marjoribanks J, Kronenberg F et al. · Cochrane Database Syst Rev 2013 · Red clover, Soy isoflavones & genistein

    An independent Cochrane review of 43 trials found no conclusive proof that phytoestrogens (soy, red clover) reduce hot flashes. High-genistein soy extracts looked more promising, and placebo effects were large.

    Who
    43 RCTs, 4,364 women
    Dose
    various phytoestrogens
    Duration
    various
    Result
    No conclusive evidence of reduced hot flushes; Promensil (red clover) not better than placebo (MD -0.93/day, NS); genistein >30 mg/day may help; strong placebo effect.
    Funding
    Cochrane review (independent). Independent / academic

    PubMed · Full text (DOI)

  • Extracted or synthesized soybean isoflavones reduce menopausal hot flash frequency and severity: systematic review and meta-analysis of randomized controlled trials.

    Taku K, Melby MK, Kronenberg F et al. · Menopause 2012 · Soy isoflavones & genistein

    Pooling 17 trials, soy isoflavone supplements (about 54 mg a day) cut hot-flash frequency by about a fifth more than placebo. Products higher in genistein worked better. Results varied widely between studies.

    Who
    17 RCTs in meta-analysis
    Dose
    median 54 mg isoflavones/day
    Duration
    6 weeks–12 months
    Result
    Hot-flash frequency -20.6% and severity -26.2% vs placebo; >18.8 mg genistein about twice as effective.
    Funding
    Academic (Japan/US); funding not stated in abstract. Funding not stated

    PubMed · Full text (DOI)

  • Use of Plant-Based Therapies and Menopausal Symptoms: A Systematic Review and Meta-analysis.

    Franco OH, Chowdhury R, Troup J et al. · JAMA 2016 · Red clover, Soy isoflavones & genistein

    A JAMA analysis of 62 studies found plant estrogens such as soy cut about one hot flash a day compared with placebo – a modest effect – and most studies were of low quality.

    Who
    62 studies, 6,653 women
    Dose
    phytoestrogens and other plant therapies
    Duration
    various
    Result
    Phytoestrogens: -1.31 hot flashes/day; soy isoflavones -0.79/day; 74% of RCTs at high risk of bias.
    Funding
    Academic (Erasmus MC); industry co-funding reported in paper is not verified here. Industry-linked

    PubMed · Full text (DOI)

  • Endometrial effects of long-term treatment with phytoestrogens: a randomized, double-blind, placebo-controlled study.

    Unfer V, Casini ML, Costabile L et al. · Fertil Steril 2004 · Soy isoflavones & genistein

    Italian women took high-dose soy isoflavones (150 mg a day) or placebo for 5 years. A small number on soy developed thickening of the womb lining (3.4% vs 0%), so long-term high doses deserve caution.

    Who
    376 women with intact uterus
    Dose
    soy isoflavones 150 mg/day
    Duration
    5 years
    Result
    Endometrial hyperplasia in 3.37% on soy vs 0% placebo; no cancers.
    Funding
    Not stated in abstract. Funding not stated

    PubMed · Full text (DOI)

  • Soy and isoflavones consumption and breast cancer survival and recurrence: a systematic review and meta-analysis.

    Qiu S, Jiang C · Eur J Nutr 2019 · Soy isoflavones & genistein

    Studies following women with breast cancer found eating soy was linked to lower recurrence, not higher. These looked at soy food, not concentrated supplements.

    Who
    12 cohort studies, 37,275 breast-cancer patients
    Dose
    dietary soy/isoflavone intake
    Duration
    observational
    Result
    Pre- and post-diagnosis soy intake associated with lower recurrence; no harm signal.
    Funding
    Academic. Independent / academic

    PubMed · Full text (DOI)

  • Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomized controlled trial.

    Geller SE, Shulman LP, van Breemen RB et al. · Menopause 2009 · Black cohosh, Red clover

    In a year-long, government-funded trial, women took black cohosh, red clover, hormone therapy or a dummy pill. Only hormones beat placebo for hot flashes; both herbs looked safe but did not reduce hot flashes more than placebo.

    Who
    89 women (4 arms)
    Dose
    standardized black cohosh and red clover extracts vs CEE/MPA vs placebo
    Duration
    12 months
    Result
    Hot-flash reduction: black cohosh 34%, red clover 57%, placebo 63%, hormones 94%; neither botanical beat placebo. Both appeared safe over 12 months.
    Funding
    NIH (NCCAM/ODS) botanical center, University of Illinois – independent. Independent / academic

    PubMed · Full text (DOI)

  • Evaluation of Clinical Meaningfulness of Red Clover (Trifolium pratense L.) Extract to Relieve Hot Flushes and Menopausal Symptoms in Peri- and Post-Menopausal Women: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

    Kanadys W, Barańska A, Błaszczuk A et al. · Nutrients 2021 · Red clover

    Pooling 8 trials, red clover reduced hot flashes by about 1–2 a day more than placebo, mostly in women with frequent hot flashes taking higher doses.

    Who
    8 trials (10 comparisons)
    Dose
    red clover isoflavones
    Duration
    ~12 weeks
    Result
    -1.73 hot flushes/day vs placebo (95% CI -3.28 to -0.18), mainly in women with ≥5/day and ≥80 mg isoflavones.
    Funding
    Authors declared no conflicts. Independent / academic

    PubMed · Full text (DOI)

  • Red clover extract for alleviating hot flushes in postmenopausal women: a meta-analysis.

    Gartoulla P, Han MM · Maturitas 2014 · Red clover

    A review found red clover modestly reduced hot flashes over 3–4 months, but the benefit was no longer seen at 12 months.

    Who
    meta-analysis
    Dose
    red clover extract
    Duration
    3–4 months and 12 months
    Result
    Effective at 3–4 months (MD -1.34/day) but not at 12 months.
    Funding
    Academic (Monash). Independent / academic

    PubMed · Full text (DOI)

  • North Central Cancer Treatment Group N10C2 (Alliance): a double-blind placebo-controlled study of magnesium supplements to reduce menopausal hot flashes.

    Park H, Qin R, Smith TJ et al. · Menopause 2015 · Magnesium

    289 women who had breast cancer took magnesium (800 or 1,200 mg a day) or placebo. Magnesium did not reduce hot flashes and caused more diarrhea.

    Who
    289 women with breast-cancer history
    Dose
    magnesium oxide 800 or 1,200 mg/day
    Duration
    8 weeks (per protocol)
    Result
    No difference vs placebo in hot-flash score or frequency; more diarrhea.
    Funding
    NCI/Alliance cooperative group (public). Independent / academic

    PubMed · Full text (DOI)

The Menopause Society's 2023 statement is in the study library.

Price

Regular one-time price$59.99 (60 units, 30 days at label dose)
Cost per day$2.00
Subscription$53.99/mo (1-mo), $50.99/mo (3-mo), $47.99/mo (6-mo); BF extra 20% first sub
Price notesAmazon B0HLN3CTJL currently unavailable
In stock when checkedYes
CheckedNov 19, 2026

Ratings

Amazon: No Amazon rating

Star ratings reflect buyer satisfaction, not clinical effect.

Certifications and claims

Verified in a public registry

  • No registry listing found.

Claims made by the brand

  • “tested for purity/contaminants per FDA cGMP” Brand claim
  • “clinically studied ingredients at effective doses” Brand claim

Registry check: NSF/ANSI 173 ('Happy V'): not found

Who's behind it

BrandHappy V
Owner / companyHappy V (Miramar, FL).
FoundersDaniella Levy (CEO) & Hans Graubard (COO).
Where it's madeOwn US manufacturing facility (brand claim). Brand claim
Medical advisors named
  • Barry Peskin, MD (gynecology)
Sourcehappyv.com

Flags & safety

Legal, regulatory and quality flags

  • 5-HTP: serotonergic – caution with SSRIs/SNRIs.
  • Contains DIM, which changes how the body breaks down estrogen and may alter the effect of transdermal estradiol (Newman 2025). study
  • ConsumerLab 'Menopause Supplements Review' (soy/red clover isoflavones, black cohosh, progesterone cream) last updated 2026-10-29; product results are members-only (not accessed). Public summary: ≥50 mg soy isoflavones or ≥15 mg genistein / 28 mg daidzein for effect; only 1/3–1/2 of women are equol producers. Past rounds found products with 30–59% of listed isoflavones and a black cohosh product with lead. consumerlab.com

Ingredient safety notes

  • Flower pollen extract: Non-estrogenic in preclinical work; no significant adverse effects reported. Pollen allergy theoretical.
  • DIM: Alters estrogen metabolism; may change effect of transdermal estradiol (Newman 2025).
  • Hops (8-PN): 8-PN is a potent phytoestrogen – caution in hormone-sensitive conditions.
  • Ashwagandha: Rare liver-injury case reports exist in the literature (not reviewed here); avoid in pregnancy and with thyroid medication — standard cautions (not verified here). Trials reported raised estradiol, lower FSH/LH. Unverified
  • Soy isoflavones & genistein: Soy is a common allergen. In a 5-year trial of 150 mg/day isoflavones, endometrial hyperplasia occurred in 3.4% vs 0% on placebo (Unfer 2004). Cohort studies of soy foods in breast-cancer survivors link them with lower recurrence and show no harm signal, but the safety of concentrated isoflavone supplements after breast cancer is uncertain (NCCIH).
  • Red clover: Phytoestrogen – same caution as isoflavones in hormone-sensitive conditions; 12-month safety acceptable in Geller 2009.
  • Magnesium: Diarrhea at 800–1,200 mg magnesium oxide.

Sources

Talk to a clinician first

The Menopause Society's 2023 nonhormone position statement does not recommend any dietary supplement or herbal remedy for hot flashes, because the research is limited or mixed. Hormone therapy is an option for many women, and the statement lists non-hormonal options with evidence behind them: CBT, clinical hypnosis, SSRIs/SNRIs, gabapentin, fezolinetant (Level I), oxybutynin (I–II), weight loss, stellate ganglion block (II–III).

If hot flashes, night sweats, sleep or mood are affecting your life, talk to a clinician first. If you still want to try a supplement, the rankings below show what is actually in each one, what the research found, and who is behind it. Sources: position statement (PDF) · PubMed.

*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Solynes does not sell supplements; descriptions summarize published research and are not medical advice.